Literature DB >> 6122340

Improved deep controlled hypotension in aneurysmal surgery.

V Lüben, G Hempelmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122340     DOI: 10.1007/bf01406307

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  27 in total

1.  Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients.

Authors:  I H PAGE; A C CORCORAN; H P DUSTAN; T KOPPANYI
Journal:  Circulation       Date:  1955-02       Impact factor: 29.690

2.  Clinical evaluation of sodium nitroprusside as a hypotensive agent.

Authors:  P P MORACA; E M BITTE; D E HALE; C E WASMUTH; E F POUTASSE
Journal:  Anesthesiology       Date:  1962 Mar-Apr       Impact factor: 7.892

3.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

4.  [Controlled hypotension with sodium nitroprusside (author's transl)].

Authors:  B Landauer
Journal:  Anaesthesist       Date:  1976-06       Impact factor: 1.041

5.  The toxicity of sodium nitroprusside.

Authors:  D G McDowall; N P Keaney; J M Turner; J R Lane; Y Okuda
Journal:  Br J Anaesth       Date:  1974-05       Impact factor: 9.166

6.  Regulation of coronary blood flow during ether and halothane anaesthesia.

Authors:  G Wolff; B Claudi; M Rist; M R Wardak; W Niederer; E Graedel
Journal:  Br J Anaesth       Date:  1972-11       Impact factor: 9.166

7.  Effect of halothane on intracranial pressure gradients in the presence of intracranial space-occupying lesions.

Authors:  W Fitch; D G McDowall
Journal:  Br J Anaesth       Date:  1971-10       Impact factor: 9.166

8.  Changes in neurologic status and intracranial pressure associated with sodium nitroprusside administration.

Authors:  M L Marsh; H M Shapiro; R W Smith; L F Marshall
Journal:  Anesthesiology       Date:  1979-10       Impact factor: 7.892

9.  Sodium nitroprusside as a hypotensive agent in intracranial aneurysm surgery.

Authors:  A Rudehill; E Gordon; M Lagerkranser
Journal:  Acta Anaesthesiol Scand       Date:  1979-10       Impact factor: 2.105

10.  Metabolism of labetalol by animals and man.

Authors:  L E Martin; R Hopkins; R Bland
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.